CClinicalTrials.gg
CompletedNCT03362372MEDISTARUpdated Mar 14, 2023

Effect of the Mediterranean Diet on Lung Function in Smokers Without Previous Respiratory Disease

An interventional study of Mediterranean diet counseling in Lung Diseases, sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina. Completed at 1 site in Spain. Open to participants aged 25 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-14.

Sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
566
Allocation
Randomized
Ages
25 Years to 75 Years
Sex
All
01

Study summary

Several studies have shown the influence of the eating pattern on lung function. However, the benefits of the Mediterranean diet (DiMet) in preventing pulmonary dysfunction are not well known.

Objective: To evaluate the effect of adherence to DiMet on the deterioration of lung function in smokers.

Methodology: Design: Controlled, parallel, multicenter, cluster-randomized clinical trial. Participants: 566 active smokers with a cumulative consumption of more than 10 packets a year, within 25 to 75 year-old age group, without previous respiratory disease and who agree with the conditions of the study and sign an informed consent . Scope: 20 Primary Care Centers managed by the Catalan Health Institutes in Tarragona that will be randomly assigned to a control or an intervention group (1: 1). Intervention: During 2 years a nutritional intervention will be carried out to increase adherence to DiMet based on: 1) annual visit of personalized nutritional education, 2) annual telephone contact for intervention reinforcement, and 3) computer access to a dietary block designed ad hoc. The control group will follow their usual diet style. All participants will receive advice to quit smoking. It will be evaluated: a) pulmonary function by forced spirometry and b) adherence to the DiMet with a questionnaire of 14 items and biological determinations. Statistical analysis: For intention to treat. The unit of analysis will be the individual smoker. Parameters of pulmonary function and adherence to the DiMet of both groups will be compared.

Expected results: DiMet prevents the appearance of altered lung function in smokers without previous respiratory pathology. Thus, DiMet will be key in pulmonary prevention, together with the fundamental recommendation of smoking cessation.

Read the detailed description

Several studies have shown the influence of the eating pattern on lung function. However, the benefits of the Mediterranean diet (DiMet) in preventing pulmonary dysfunction are not well known.

Objective: To evaluate the effect of adherence to DiMet on the deterioration of lung function in smokers.

Methodology: Design: Controlled, parallel, multicenter, cluster-randomized clinical trial. Participants: 566 active smokers with a cumulative consumption of more than 10 packets a year, within 25 to 75 year-old age group, without previous respiratory disease and who agree with the conditions of the study and sign an informed consent . Scope: 20 Primary Care Centers managed by the Catalan Health Institutes in Tarragona that will be randomly assigned to a control or an intervention group (1: 1). Intervention: During 2 years a nutritional intervention will be carried out to increase adherence to DiMet based on: 1) annual visit of personalized nutritional education, 2) annual telephone contact for intervention reinforcement, and 3) computer access to a dietary block designed ad hoc. The control group will follow their usual diet style. All participants will receive advice to quit smoking. It will be evaluated: a) pulmonary function by forced spirometry and b) adherence to the DiMet with a questionnaire of 14 items and biological determinations. Statistical analysis: For intention to treat. The unit of analysis will be the individual smoker. Parameters of pulmonary function and adherence to the DiMet of both groups will be compared.

Expected results: DiMet prevents the appearance of altered lung function in smokers without previous respiratory pathology. Thus, DiMet will be key in pulmonary prevention, together with the fundamental recommendation of smoking cessation.

02

Conditions studied

  • Lung Diseases

Browse trials for

03

Who can participate

Ages eligible
25 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Active smoking and cumulative consumption ≥10 pack-years.
  • Age between 25-75 years.
  • Internet connection.

Exclusion criteria

Exclusion Criteria:

  • History of respiratory disease.
  • Chronic or terminal disorder that alters basal parameters.
  • Any reason that limits follow up.
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
566 participants (actual)

Study arms

  • Experimental
    INTERVENTION GROUP: MEDITERRANEAN DIET COUNSELING

    During 2 years a nutritional intervention will be carried out to increase adherence to DiMet based on: annual visit of personalized nutritional education, a telephone contact for intervention reinforcement and computer access to a nutrition blog

    Behavioral: Mediterranean diet counseling

  • No intervention
    CONTROL GROUP: WITHOUT CHANGES IN DIET

    The participants of health centers will carry out the same 5 visits (3 individual visits and 2 phone calls), although no changes are induced in their usual diet and they will not be offered access to the nutritional blog.

Interventions

  • BehavioralMediterranean diet counseling

    The participants of the intervention CAP will enter into an educational program to increase adherence to the DiMet that will integrate three operational components: 1. Explain the particularities of DiMet and the benefits of its monitoring. It will be an individual visit of 25-30 minutes (V1) where the study variables will be collected and the medical tests will be performed and repeated annually for two years (V3 and V5). 2. Clarify the doubts of the DiMet monitoring and the advice received. It will be a telephone visit to reinforce the intervention, with annual frequency, for two years (V2 and V4). 3. Report on DiMet's own foods, cooking habits, adapted recipes and other related topics. It will be for access to an ad hoc designed nutrition blog.

05

What researchers measure

Primary outcomes

  1. Change in lung function values in smokers without previous respiratory disease

    Changes in lung function measured by spirometry. An altered lung function was considered if values of FVC \<80% and / or FEV1 \<80% and / or FEV1 / FVC \<0.7

    Time frame: 2 years

Secondary outcomes

  1. Nutritional intervention

    The effectiveness of the intervention will be measured by dietary changes by a food frequency questionnaire

    Time frame: 2 years

  2. Nutritional intervention

    Adherence to the Mediterranean diet will be measured by dietary changes in a mediterranean diet adherence score of 14-ítem

    Time frame: 2 years

  3. Anthropometric parameters

    Changes in anthropometric parameters: weight in kilograms and height in meters. Weight and height will be combined to report BMI in kg/m2

    Time frame: 2 years

  4. Anthropometric parameters

    Changes in anthropometric parameters: abdominal perimeter

    Time frame: 2 years

  5. Changes in food consumption markers

    Changes in food consumption markers: excreted of total polyphenols in fresh urine.

    Time frame: 2 years

  6. Changes in inflammation markers

    Changes in serum inflammation markers: high-sensitivity C-reactive protein

    Time frame: 2 years

  7. Changes in inflammation markers

    Changes in serum inflammation markers: interleukin-6

    Time frame: 2 years

06

Study locations

1 site
  • Jordi Gol i Gurina Foundation
    Barcelona, 08007, Spain
07

References and documents

Publications

  • Martin-Lujan F, Catalin RE, Salamanca-Gonzalez P, Sorli-Aguilar M, Santigosa-Ayala A, Valls-Zamora RM, Martin-Vergara N, Canela-Armengol T, Arija-Val V, Sola-Alberich R. A clinical trial to evaluate the effect of the Mediterranean diet on smokers lung function. NPJ Prim Care Respir Med. 2019 Nov 27;29(1):40. doi: 10.1038/s41533-019-0153-7. PubMed 31776344 ↗
  • Catalin RE, Martin-Lujan F, Salamanca-Gonzalez P, Palleja-Millan M, Villalobos F, Santigosa-Ayala A, Pedret A, Valls-Zamora RM, Sola R, On Behalf Of The Medistar Research Group Investigators. Mediterranean Diet and Lung Function in Adults Current Smokers: A Cross-Sectional Analysis in the MEDISTAR Project. Nutrients. 2023 Mar 3;15(5):1272. doi: 10.3390/nu15051272. PubMed 36904270 ↗

Study documents

  • Protocol, analysis plan and consent form · Nov 28, 2017

Documents are hosted by the registry — open the source record to download them.

08

Registry details

Key details

Study ID
NCT03362372
Lead sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Collaborators
Preventive Services and Health Promotion Research Network
Responsible party
Sponsor
First posted
Dec 5, 2017
Start date
Jun 1, 2017
Primary completion
Jun 1, 2018
Completion
Jul 1, 2020
Last update
Mar 14, 2023

Study contacts

Francisco Martín Luján
principal investigator · Catalan Institute of Health

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion